These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms. Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690 [TBL] [Abstract][Full Text] [Related]
5. Treatment by prostatic injection of acute urinary retention due to prostatic hyperplasia. Shipman JJ; Akilie AN Br Med J; 1967 May; 2(5549):418-9. PubMed ID: 4164447 [No Abstract] [Full Text] [Related]
6. Natural history of benign prostatic hypertrophy and acute urinary retention. Birkhoff JD; Wiederhorn AR; Hamilton ML; Zinsser HH Urology; 1976 Jan; 7(1):48-52. PubMed ID: 54971 [TBL] [Abstract][Full Text] [Related]
7. [Basis of acute urinary retention in patients with prostatic hypertrophy and its etiology]. Jíra M Rozhl Chir; 1969 Dec; 48(11):513-7. PubMed ID: 4188598 [No Abstract] [Full Text] [Related]
8. [Correction of urination disorders caused by benign prostatic hyperplasia in cardiac surgery]. Koraev KN Khirurgiia (Mosk); 2003; (1):19-21. PubMed ID: 12645203 [TBL] [Abstract][Full Text] [Related]
9. [Conservative therapy of prostatic hyperplasia with urinary retention]. Djulepa J Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601 [No Abstract] [Full Text] [Related]
10. Effects of an alpha 1-adrenergic blocker (prazosin HCl) on micturition disturbances associated with benign prostatic hypertrophy. Shimizu K; Nakai K; Imai K; Yamanaka H Urol Int; 1990; 45 Suppl 1():36-9. PubMed ID: 1690479 [TBL] [Abstract][Full Text] [Related]
11. The use of alpha-adrenergic blockers in benign prostatic obstruction. Caine M; Pfau A; Perlberg S Br J Urol; 1976 Aug; 48(4):255-63. PubMed ID: 61054 [TBL] [Abstract][Full Text] [Related]
12. Significance of acute urinary retention due to intravesical obstruction. Breum L; Klarskov P; Munck LK; Nielsen TH; Nordestgaard AG Scand J Urol Nephrol; 1982; 16(1):21-4. PubMed ID: 7089491 [TBL] [Abstract][Full Text] [Related]
13. Mefenamic acid in urinary retention. Smith TC Br Med J (Clin Res Ed); 1981 Feb; 282(6264):618. PubMed ID: 6162504 [No Abstract] [Full Text] [Related]
14. [Tactics of the surgical treatment of patients with prostatic adenoma and acute urinary retention]. Borzhievskiĭ TsK; Stroĭ AA Urol Nefrol (Mosk); 1987; (1):39-43. PubMed ID: 2436372 [No Abstract] [Full Text] [Related]
15. New clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms. Yoshida M; Kudoh J; Homma Y; Kawabe K Int J Urol; 2012 Apr; 19(4):306-16. PubMed ID: 22251148 [TBL] [Abstract][Full Text] [Related]
16. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia. Gallegos PJ; Frazee LA Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of an alpha-blocker, alfuzosin, on urinary disorders in men with prostatic adenoma. Intermediate results of a European multicenter study]. Jardin A Ann Urol (Paris); 1988; 22(5):333-40. PubMed ID: 2462402 [TBL] [Abstract][Full Text] [Related]
18. [Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia]. de la Taille A Prog Urol; 2008 Apr; 18 Suppl 3():S53-7. PubMed ID: 18455085 [TBL] [Abstract][Full Text] [Related]